RAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS
Open Access
- 9 September 2018
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 8,p. 13-20
Abstract
Aim.To investigate on the relation of lipoproteide(a) (Lpa), subfractions of atherogenic lipoproteides and titers of specific autoantibodies (autoAb) with the presence and severity of carotid arteries (CA) lesion in statin-naïve patients with severe hypercholesterolemia.Materialandmethods.To the study, 133 statin-naïve patients included, age 18 to 75 y.o., with absent clinical signs of coronary heart disease, and with first time diagnosed severe hypercholesterolemia (total cholesterol >7,5 mM/L and/or low density lipoproteides cholesterol >4,9 mM/L) with ultrasound duplex scan data of CA. All patients underwent measurement of Lpa concentration, lipid profile, subfractional content of apoB-100-containing lipoproteides and autoAb titer against them.Results.According to the data from duplex CA scan, patients were selected to 2 groups: control group (n=76) with no CA atherosclerosis; main group — patients with CA stenosis >20% (n=57). The participants of main group were older than controls, with no other clinical or lipid profile differences. Titre of autoAb IgM specific for Lpa and its oxidized modifications was significantly lower in CA atherosclerosis comparing to controls. The grade of CA stenosis in severe hypercholesterolemia patients positively correlated with age (r=0,24, p=0,005) and negatively — with autoAb IgM to apoB100-containing lipoproteides (r=-0,28 and r=-0,26, pConclusion.In patients with severe hypercholesterolemia Lpa is an autoantigen, and IgM autoantibodies to Lpa play antiatherogenic role.Keywords
This publication has 14 references indexed in Scilit:
- Lipoprotein(a) in clinical practice: New perspectives from basic and translational scienceCritical Reviews in Clinical Laboratory Sciences, 2017
- Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular EventsArteriosclerosis, Thrombosis, and Vascular Biology, 2017
- Autoantibodies Against Lipoprotein(a) in Patients With Coronary Heart DiseaseKardiologiia, 2014
- Oxidation-specific epitopes as targets for biotheranostic applications in humansCurrent Opinion in Lipidology, 2013
- Foam cells in atherosclerosisClinica Chimica Acta, 2013
- Small dense LDL: An emerging risk factor for cardiovascular diseaseClinica Chimica Acta, 2012
- Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular EventsJACC, 2012
- Lipoprotein Oxidation and Modification2009
- Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markersAutoimmunity, 2009
- Incidence of Lp(a) Lipoprotein among Populations1990